22nd Century Group (NASDAQ:XXII) Releases Earnings Results

22nd Century Group (NASDAQ:XXII) announced its quarterly earnings data on Tuesday. The biotechnology company reported ($0.54) earnings per share (EPS) for the quarter, reports. The company had revenue of $5.95 million during the quarter. 22nd Century Group had a negative net margin of 144.09% and a negative return on equity of 380.39%.

22nd Century Group Trading Down 5.1 %

Shares of XXII stock opened at $0.09 on Friday. 22nd Century Group has a 12 month low of $0.09 and a 12 month high of $5.69. The company has a current ratio of 1.09, a quick ratio of 0.67 and a debt-to-equity ratio of 1.59. The firm has a fifty day moving average price of $0.18 and a 200 day moving average price of $0.63.

Institutional Trading of 22nd Century Group

A hedge fund recently raised its stake in 22nd Century Group stock. Anson Funds Management LP increased its holdings in shares of 22nd Century Group, Inc. (NASDAQ:XXII) by 106.9% in the 1st quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 6,577,814 shares of the biotechnology company’s stock after purchasing an additional 3,399,323 shares during the quarter. Anson Funds Management LP owned approximately 83.28% of 22nd Century Group worth $789,000 at the end of the most recent quarter. 18.06% of the stock is owned by institutional investors and hedge funds.

Analysts Set New Price Targets

Separately, StockNews.com started coverage on shares of 22nd Century Group in a report on Wednesday. They issued a “sell” rating on the stock.

22nd Century Group Company Profile

22nd Century Group, Inc, a tobacco products company, engages in the sale and distribution of its own proprietary new reduced nicotine tobacco products. The company offers reduced nicotine content tobacco plants and very low nicotine combustible cigarette products. It also provides contract manufacturing services for conventional combustible tobacco products for third-party brands.